|
rs1057516674
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
|
rs1057520529
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
|
rs1060499688
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
|
rs1114167422
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
|
rs1554544862
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
|
rs33950507
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
|
rs41469945
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
|
rs747506979
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
|
rs76992529
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
|
rs878853314
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
|
rs878853315
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
|
rs1695
|
|
|
0.030 |
GeneticVariation |
BEFREE |
<i>GSTP1</i> rs1695 showed the smallest p value for hematotoxicity association, and the <sup>105</sup>Ile wild type allele had a significantly higher risk of severe hematotoxicity (neutropenia G4, thrombocytopenia ≥ G3 and anemia ≥ G3) than the <sup>105</sup>Val allele (p=0.00034, odds ratio=5.71 (95% confidence interval:1.77-18.44)).
|
30038720 |
2018 |
|
rs7270101
|
|
|
0.070 |
GeneticVariation |
BEFREE |
Anaemia was observed in 87.5% and 86.2% of treated patients with AA (rs7270101) and CC genotypes (rs1127354), respectively.
|
26154744 |
2015 |
|
rs1127354
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Anaemia was observed in 87.5% and 86.2% of treated patients with AA (rs7270101) and CC genotypes (rs1127354), respectively.
|
26154744 |
2015 |
|
rs121908117
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Anaemia in TREX1 D18N mice is accompanied by increased erythropoietin (Epo), normal hepcidin levels and the TREX1 D18N mice display an inappropriate response to anaemic challenge.
|
30422000 |
2018 |
|
rs1559810905
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
An extremely severe case of Aicardi-Goutières syndrome 7 with a novel variant in IFIH1.
|
30965144 |
2020 |
|
rs77375493
|
|
|
0.040 |
GeneticVariation |
BEFREE |
Apoptotic resistance in MMM correlated with anemia (P=0.01) and the JAK2-V617F (P=0.01).
|
16871275 |
2006 |
|
rs4150558
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Association with anemia and neutropenia were found in GP regimen. rs4150558 showed significant association with anemia in NP regimen.
|
28924235 |
2017 |
|
rs1289324472
|
|
|
0.010 |
GeneticVariation |
BEFREE |
At diagnosis, N370S homozygotes as compared to N370S compound heterozygotes had the following clinical characteristics: irreversible skeletal lesions 17% (34/198) for N370S homozygotes versus 26% (76/290) for N370S compound heterozygotes; anaemia 18% (59/327) versus 29% (145/494); thrombocytopenia 52% (170/327) versus 62% (281/453); hepatomegaly 44% (83/190) versus 72% (141/195); splenomegaly 73% (142/194) versus 91% (178/195); and osteopenia or osteoporosis 48.6% (34/70) versus 51% (25/49).
|
18979180 |
2008 |
|
rs76763715
|
|
|
0.010 |
GeneticVariation |
BEFREE |
At diagnosis, N370S homozygotes as compared to N370S compound heterozygotes had the following clinical characteristics: irreversible skeletal lesions 17% (34/198) for N370S homozygotes versus 26% (76/290) for N370S compound heterozygotes; anaemia 18% (59/327) versus 29% (145/494); thrombocytopenia 52% (170/327) versus 62% (281/453); hepatomegaly 44% (83/190) versus 72% (141/195); splenomegaly 73% (142/194) versus 91% (178/195); and osteopenia or osteoporosis 48.6% (34/70) versus 51% (25/49).
|
18979180 |
2008 |
|
rs6051702
|
|
|
0.040 |
GeneticVariation |
BEFREE |
Baseline testing of rs6051702 may identify the subset of patients at greatest risk for RBV-induced anaemia using interferon-free hepatitis C therapies.
|
28198349 |
2017 |
|
rs12979860
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Early anemia (81:48:41%) and rapid virological response (83:91:92%) increased the predictive efficiency of IL28B rs12979860 genotype distribution (CC:CT:TT).
|
22711348 |
2012 |
|
rs368002262
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Expression cloning and sequencing of the cDNA obtained from GroD1 revealed a point mutation, Gly-189 --> Glu, in glucose-6-phosphate isomerase (GPI), a glycolytic enzyme involved in an inherited disorder that results in anemia and neuromuscular symptoms in humans.
|
19903819 |
2010 |
|
rs1799945
|
|
|
0.010 |
GeneticVariation |
BEFREE |
From what we observed in our study, C282Y/H63D HFE gene mutations are not related to degrees of anemia or iron stores in CRI patients receiving intravenous iron supplementation (P > 0.10).
|
16138214 |
2005 |
|
rs708567
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Furthermore, IL17RE rs708567 GA and hHbS rs334 AT individuals were associated with protection from uncomplicated malaria and anaemia respectively in this study.
|
24312262 |
2013 |